Has Christopher Thompson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,341 in general payments to Christopher Thompson, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Thompson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Thompson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Thompson, MD

Otolaryngology · Abilene, TXNPI 1447570619

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Acclarent, Inc at 57.8% of the total. Reporting peaked in 2019 at $583 and has fallen 91.2% since, to $51 in 2025. That places this record below the midpoint for otolaryngology clinicians in TX, where the typical reported total is $1,798.

$1,341in general payments, 2019–2025

Across 42 payments — averaging $31.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acclarent, Inc$776
Stryker$169
Intersect ENT, Inc.$98
Medtronic$86
Sanofi$68
Aerin Medical Inc.$34
plus $111 from 6 others

$38,656in research payments, 2019–2025

Across 15 payments — averaging $2577.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$39K

What the payments were for

Food & beverage$1,341100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acclarent, Inc	18	$776
Stryker	6	$169
Intersect ENT, Inc.	4	$98
Medtronic(2 entities)	4	$86
Sanofi	2	$68
Aerin Medical Inc.	2	$34
Smith+Nephew	1	$31
AstraZeneca	1	$20
Regeneron Healthcare Solutions, Inc.	1	$17
GSK	1	$16
Novartis	1	$13
Covidien LP	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RELIEVA CIRCA Ethmoid Punch$134

How this compares

$1,341 in reported general payments places this provider in the 40th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas →

Medicare billing

Part B allowed, 2024

$150,951

Medicare patients

394

Services billed

2,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	14	$1,241
Ofloxacin	39	$1,059
Esomeprazole Magnesium	31	$879
Levothyroxine Sodium	90	$692
Fluticasone Propionate	34	$392
Azelastine Hcl	16	$388
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	17	$248
Montelukast Sodium	15	$173
Mupirocin	15	$136
Acetaminophen-CodeineAcetaminophen With Codeine	17	$107
Pantoprazole Sodium	12	$103
Methylprednisolone	15	$79
Promethazine Hcl	13	$37

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Abilene

Marc DeanFort Worth$486K
Amber LuongHouston$426K
Arjuna KuperanHouston$348K
Ronald KuppersmithCollege Station$325K
Ron KarniHouston$317K
Philip ChenSan Antonio$305K
Jordan RihaniSouthlake$280K
Keith MathenyFrisco$269K
Martin CitardiHouston$245K
James AtkinsSan Antonio$205K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →